Inflammation Research

, Volume 52, Supplement 1, pp s49–s50

H1 antagonists: receptor affinity versus selectivity

Authors

  • M. Gillard
    • UCB Pharma Sector, In Vitro Pharmacology, Chemin Du Foriest, 1420 Braine l'Alleud, Belgium, Fax: ++ 32 2 386 33 97, e-mail: michel.gillard@ucb-group.com
  • B. Christophe
    • UCB Pharma Sector, In Vitro Pharmacology, Chemin Du Foriest, 1420 Braine l'Alleud, Belgium, Fax: ++ 32 2 386 33 97, e-mail: michel.gillard@ucb-group.com
  • B. Wels
    • UCB Research Inc., Cambridge, Ma, USA
  • M. Peck
    • UCB Pharma Sector, In Vitro Pharmacology, Chemin Du Foriest, 1420 Braine l'Alleud, Belgium, Fax: ++ 32 2 386 33 97, e-mail: michel.gillard@ucb-group.com
  • R. Massingham
    • UCB Pharma Sector, In Vitro Pharmacology, Chemin Du Foriest, 1420 Braine l'Alleud, Belgium, Fax: ++ 32 2 386 33 97, e-mail: michel.gillard@ucb-group.com
  • P. Chatelain
    • UCB Pharma Sector, In Vitro Pharmacology, Chemin Du Foriest, 1420 Braine l'Alleud, Belgium, Fax: ++ 32 2 386 33 97, e-mail: michel.gillard@ucb-group.com
Regular paper

DOI: 10.1007/s000110300050

Cite this article as:
Gillard, M., Christophe, B., Wels, B. et al. Inflamm. res. (2003) 52: s49. doi:10.1007/s000110300050

Copyright information

© Birkhäuser Verlag, 2003